Zydus R&D ties up with Danish Pantheco

By Our Staff Correspondent

MUMBAI, JAN. 10. Zydus Cadila has signed a three year collaborative R&D agreement in anti-bacterials with Danish Pantheco. Pantheco and Zydus Research Centre will join efforts in the research and development of new antibiotic compounds based on existing classes of antibiotic drugs.

According to the agreement, Zydus will undertake all chemistry, preliminary screening and initial characterisation of new compounds with anti-bacterial activity. Pantheco will undertake further profiling of the drug candidates and perform all necessary pre-clinical and early clinical development studies until Phase IA clinical trials. Each company will cover its own research and development costs and profits will be shared on a fifty-fifty basis.

``This agreement with Zydus Research Centre gives us access to new antibacterial compounds and in addition to our current in- house anti-bacterial programmes, this collaboration strengthens our efforts to efficiently meet our overall objective of developing new antibacterial drugs,'' said Mr. Anker Lundemose, CEO of Panthco.

The Zydus Research Centre (ZRC) which spearheads Zydus Cadila's research activities is highly skilled in medicinal chemistry and traditional pharmacology and Indian companies have in the past delivered patented preclinical compounds to European pharma companies with success.

Send this article to Friends by E-Mail

Section  : Business
Previous : Rupee ends higher
Next     : MUL hikes prices